Summary.-Twice-weekly intratracheal instillations in rats of up to 24 mg of Fraction (R + P)G suspended in either infusine (I) or buffered saline/gelatine (BS/G) gave rise to foci of squamous metaplasia of alveolar epithelium (SqM) and squamous neoplasms (SqN). Fraction (R + P)G, which is a fraction of cigarettesmoke condensate almost as tumorigenic for mouse skin as the nearly 30 x larger mass of condensate from which it is derived, could be given in this way for up to 40 weeks without excessive mortality or any marked effect on the rate of body-weight gain. By contrast, similar treatment with Fraction N(QG), a fraction having very low tumorigenic activity for mouse skin, induced no SqN and barely any excess of SqM over that induced by either vehicle alone.
DESPITE several attempts, malignant tumours have not been produced in significant numbers in the lungs of experimental animals by exposing them to cigarette smoke (Dontenwill et al., 1973; Bernfield et al., 1974; Davis et al., 1975a) . Lung tumours have been readily induced by carcinogens administered by intratracheal instillation (Shabad, 1962; Pylev, 1963; Schreiber et al., 1972; Davis et al., 1975b) . Davis et al. (1975c) also showed that the repeated fortnightly instillation of cigarette-smoke condensate (SWS) was associated with increased incidence of cuboidal columnar metaplasia (CCM) and squamous metaplasia (SqM), although such treatment failed to induce squamous neoplasms (SqN) in the lungs. Certain fractions of SWS known to be carcinogenic to mouse skin also produced CCM and SqM. In addition, Fraction P(SG), which contains most of the polycyclic aromatic hydrocarbons of cigarette smoke, produced a low incidence of benign or doubtfully malignant SqN, similar to those induced by the known carcinogen, benz(a)pyrene.
The object of the first experiment described in the present report was to determine whether rats will tolerate more frequent intratracheal instillations of SWS or smoke-condensate fractions and, if so, whether such treatment leads to the early development of SqN, or a high incidence of SqN, and/or to the development of SqN of undoubted malignancy. The object of the second experiment was to compare the effects on rat lung of 2 fractions of tobacco-smoke condensate, one of which (Fraction (R + P)GC) is far more tumorigenic for mouse skin than the other (Fraction N(QG)).
MATERIALS AND METHODS
Rats.-Non-inbred Wistar specific-pathogen-free (SPF) rats obtained from Olac (Southern) Ltd, of Blackthorn, near Bicester, Oxon, were used for the 2 main experiments. Non-inbred Wistar SPF rats bred in our own laboratories (strain TRCL) were used for preliminary short-term toxicity trials.
In each experiment, female rats aged 12 weeks were allocated by a non-selective process to the various treatment groups. Animals were housed in groups of 5 in solidfloor polypropylene cages with sawdust bedding, in natural daylight at 22 ± 3°C. They were fed Oxoid 41B laboratory animal diet and water ad libitum.
Preparation of condensate and fractions.-A single batch of plain cigarettes (TRC code T57) manufactured from a composite blend of flue-cured tobacco was used as the source for all condensate.
Smoke condensate was prepared by smoking cigarettes in the automatic smoking machine described by Day (1967) . The standard smoking parameters used were: puff volume, 35 ml; puff duration, 2 s; puff frequency, 1 min; butt length, 20 mm. Smoke was collected in a glass trap cooled by immersion in acetone and crushed solid CO2 (Davies and Day, 1969) . It was stored at -29°C until used. Such a condensate was referred to as "stale whole-smoke condensate" (SWS).
The fractionation scheme has been described in detail (Whitehead and Rothwell, 1969; Lee et al., 1977) . The origins of the fractions used in these experiments were:
Fractions G, (R + P)G and Q(G). Treatment and observation.-The method for intratracheal instillation is described in Davis et al. (1975a) . Animals were inspected daily for state of general health, clinically examined at the times of treatment, and weighed wveekly. The techniques for post mortem examination and microscopic examination of tissues are described in Davis et al. (1975a) .
Histopathological evaluation.-All rats that died or were killed during or at the end of the experiments were examined post mortem. Four standard 6 um sections were prepared of the lungs of rats showing no localized lesions at necropsy. Additional sections were taken through macroscopically visible tumours, unless these were adequately represented in standard sections. Sections wvere stained with haematoxylin and eosin and scored in respect of 4 kinds of lesion: (i) aggregates of brown-pigment-laden alveolar macrophages (GBM); (ii) foci of cuboidal/ columnar metaplasia of alveolar epithelium (CCM); (iii) foci of squamous metaplasia of alveolar epithelium (SqM) and iv) squamous neoplasms (SqN). Slightly different scoring systems were used in the 2 experiments, and details are given separately in the text describing each experiment. Histopathological evaluations were blind", in the sense that the pathologist (FJCR) w%as unaware of the treatment rats had received or of the week of the experiment in which they died or wi-ere killed.
Statistical evaluation.-Significance tests wvere carried out to assess between-group differences of 3 different parameters: (i) proportion of rats with a given lesion; (ii) mean number of lesions per rat and (iii) mean grade of lesion per rat. If the results being considered were based on rats dying in a single interval, chi-squared analysis w%as used for the first parameters and one-wTay analysis of variance for the second or third parameters. If a simultaneous assessment of results from rats dying in more than one interval was being made, Peto's method for incidental tumours (1974) was used for the first parameter, in order to correct for possible differences in survival between the groups. The other 2 parameters w%ere analysed by unbalanrced two-way analysis of variance, to give betweengroup differences "adjusted for time of death".
All analyses of variance were carried out after a suitable variance-stabilizing transformation of the data. For the second parameters, which are counts, the square-root transformation y= V/x -,as used, while for the third parameters, w%hich are scores out of a maximum possible (M) the transformnation y = loge[(x + 1)/(M + 1 -x)] was used.
Analysis of variance, this time of untransformed data, was also used to compare groups in terms of body weight and bodyw-eight gain.
EXPERIMENTAL I)ESIGN ANT) RESULTS

Experiment I
Preliminary toxicity studies showed that rats would tolerate twice-weekly intratracheal instillations of 12 mg of Fraction (R + P)G in infusine, but not similar exposure to whole condensate (SWS) or Fraction G(. The purpose of Exp. I was to see whether even higher doses of (R + P)G would be tolerated, and if so what effects such treatment would have.
Seventy rats were allocated non-selectively to 3 treatment groups, each of 18 animals, and 3 control groups, each of 4-6 animals. Rats in the first 3 groups received twice-weekly instillation of 12 mg, 24 mg or 48 mg of Fraction (R + P)G in infusine (total volume per instillation = 0 2 ml). One control group (6 rats) was similarly exposed to infusine only; another control group (6 rats) was anaesthetized twice-weekly but received no treatment; and the remaining control group (4 rats) received neither anaesthetic nor treatment. Treatment continued for 34 weeks, after which a proportion of the survivors were killed. The remaining rats were observed until the termination of the experiment at 84 weeks. The design of the study is t All macroscopically observed tumours were found on microscopic examination to be squamous neoplasms.
However several small squamous neoplasms not observed at necropsy were discovered on microscopic examination of the lungs. t 7 treated rats in groups 1-3 were too autolysed for assessment and only 6 control rats (groups [4] [5] [6] were assessed. Otherwise the Table refers to all rats in the experiment, irrespective of when they died or were killed. evident from Table I , which also gives survival data. Table I shows that twice-weekly intratracheal instillations of 12 mg or 24 mg, but not 48 mg, (R + P)G were well tolerated in terms of survival. As shown in Table II , the mean body weight of rats in all the groups increased during the study. Analysis of variance showed that, though there were marked differences between the 6 groups in weight gain in the first 4 weeks (P < 0-001) due mainly to a marked dose-response trend, these were not subsequently statistically significant. However the (R + P)G-treated groups had consistently lower weight gains than the infusine-only or anaesthetic-only groups. The behaviour of the untreated group was surprisingly erratic. Tables III and IV summarize As all 3 lesions studied in Table IV Preliminary toxicity studies were undertaken to identify a suitable fraction of smoke condensate which was not tumorigenic for mouse-skin and which would be tolerated by rats exposed to it by intratracheal instillation. Short-term studies indicated that Fractions K(QG), L(QG), M(QG) and HC(QG), and also dotriacontane, hexadecane and liquid paraffin (BPC), were too toxic, but that Fraction N(QG) might be sufficiently well-tolerated for the purposes of the proposed study.
A preliminary short-term study was also carried out to see whether the frequency of dosing could be increased from twice to 3 x weekly without an adverse effect on survival of rats given 12 or 24 mg of (R + P)G. The results showed that mortality with 3 x weekly treatment was excessive and it was, therefore, decided to continue with 2 x weekly application in Experiment II.
The design of Experiment II, involving a comparison of the effects of Fractions (R + P)G and N(QG) with I or BS/G as vehicle is evident from Groups were compared in respect of (i) incidence of macroscopically visible lung tumours, (ii) severity of chronic respiratory diseases (CRD), (iii) incidence of aggregates of GBM, (iv) incidence of CCM lesions, (v) incidence of SqM lesions and (vi) The response to Fraction (R + P)G in I was significantly higher than that to the same fraction in BS/G (P < 0 01) and also significantly higher than that to N(QGC) in the same vehicle (P < 0 001). Macroscopic examination revealed no treatment-related differences in incidences of lesions outside the respiratory tract.
DISCUSSION
The results of the first experiment indicated that Fraction (R + P)G, which 3-3 (6) 0.0 (7) 00 (6) 0 0 (6) 0 * 3 (6) 0-1 (11) 15-2 (13) 6-1 (12) 2 -9 (9) 1-0 (1) 0.-4 (17) 0-2 (10) forms only 3.5O% of whole-smoke condensate and is almost as tumorigenic for mouse skin as the much larger mass of whole-smoke condensate from which it is derived (Lee et al., 1977) pigment (GBM) and foci of cuboidal/ columnar metaplasia ofalveolar epithelium (CCM). This increase was time-related but apparently irrespective of dose, although the apparent lack of dose response may have been due to the response being maximal at the lowest dose studied. Some of the SqN observed were doubtfully malignant, but no unequivocally malignant lung tumour was seen. However, only 5 treated rats survived for longer than 60 weeks. The second main experiment showed that, whereas a fraction of cigarettesmoke condensate (Fraction (R + P)G) which is relatively strongly tumorigenic for mouse skin gives rise to SqM and SqN when instilled into the lungs of rats, another fraction (Fraction N(QG)) which is more or less without tumorigenicity for mouse skin, was almost entirely unable to induce SqM or SqN when instilled into the lungs of rats. By contrast, both fractions were active in causing GBM and CCM, suggesting that these lesions are not specific to the tumour process.
An important aspect of the findings is that the effect of Fraction (R + P)G on the incidence of SqM was already evident at 10 weeks. This may mean that the intratracheal instillation technique with SqM as the end point could be used as a shortterm test for predicting tumorigenicity of smoke components.
In the case of mouse skin, there is evidence that the tumorigenic activity of Fractions (R + P)G from different smoke condensates parallel the activities of the smoke condensates from which they are derived (Lee et al., 1977) . If this is as true for rat lung as for mouse skin, tests on rat lung of Fraction (R + P)G from different condensates might be useful for comparing the overall tumorigenicity of different condensates.
In neither of the 2 studies reported was it possible to keep more than a few animals for long-term observation. It is perhaps not surprising, therefore, that no unequivocally malignant lung tumour was seen.
Further studies will be needed to see how useful a predictor of tumorigenicity the rat lung instillation assay is, and whether truly malignant lung neoplasms can be induced by this method.
